Contents
Brachytherapy source Medicare billing provides separate payment for radioactive sources used in hospital outpatient treatment, with units defined by the source code. The Centers for Medicare & Medicaid Services also permits billing for certain sources ordered for a patient but not implanted, under specific conditions. The fraud question is whether a hospital knowingly charged Medicare for sources that did not meet those conditions. If you work in radiation oncology, inventory or billing, you may know why the number charged differs from the number implanted. The prescription, acquisition, treatment and disposal records give that difference its meaning.
Medicare generally includes an implanted medical device’s cost in the hospital’s payment for the service. Brachytherapy sources have their own separate-payment rule. That distinction matters in medical device reimbursement fraud because the source’s identity and quantity directly enter the payment calculation.
Medicare’s hospital outpatient claims manual says providers must bill the sources in addition to the services used to administer and deliver brachytherapy. The eligible sources contain a radioactive isotope, and payment reflects their number, isotope, radioactive intensity and stranded or non-stranded configuration. For the hospital employee reviewing a source charge, the useful comparison is between the product obtained for the patient and the source description and quantity on the bill.
Seed-like sources are generally billed per source, including the sources within a strand. The code’s full description defines the unit of measurement. One strand, several sources. That strand carries a source count of its own, even when purchasing or inventory describes it as an item.
We compare the acquisition and treatment records in the same units as the claim. A strand count and a source count can describe the same material in different ways. The isotope, intensity and configuration belong beside the quantity, so the comparison explains which radioactive sources the hospital actually acquired and used.
For new sources without established codes, the hospital outpatient claims manual identifies C2698 for stranded sources and C2699 for non-stranded sources, both described as not otherwise specified. Both use a per-source unit. The manual bases payment on the lowest stranded or non-stranded source rate, respectively, so the configuration affects the payment as well as the count.
A hospital may bill certain unimplanted sources when most of the prescribed sources were implanted and relatively few remained unused because of specific clinical considerations. Medicare treats those remaining sources as used in the patient’s care when all the conditions of its patient-specific exception are met.
The hospital had to acquire the sources for that particular patient, under a physician’s prescription consistent with standard clinical practice and high-quality brachytherapy treatment. The purchase had to ensure that the clinically appropriate number was available for implantation. The leftover sources could not have been implanted in anyone else, and the hospital had to dispose of them under all applicable handling requirements.
Medicare generally expects the unimplanted sources to represent only a small fraction of the sources actually implanted. Under these conditions, the beneficiary owes a copayment on all the sources billed, including the qualifying unimplanted sources. If a hospital knowingly pads that count, taxpayers and the patient paying for health care both bear the charge. We want to know who decided those extra units belonged on the bill.
The physician’s prescription and the hospital’s acquisition record connect the intended treatment to the sources obtained for that patient. The treatment record explains what was implanted and the clinical reason for leaving sources unused. Disposal records address what happened to the remainder. Together, those records let us examine the quantity and description that reached Medicare.
An employee may understand a decision that the claim alone does not explain. If you saw sources assigned to another patient, you may know why a charge attributed them to the first patient’s care. If you handled disposal, you may know what became of sources still appearing in the billed count. We work through those connections with you, including who chose the quantity sent to billing and what information they had.
A 2020 review in the Journal of Forensic and Investigative Accounting, A Forensic Accountant’s Guide to the Most Potent Federal Laws Used Against Healthcare Fraud, explains how a bill that misstates the goods provided can support a False Claims Act case. For source billing, the question is how the acquisition and treatment records compare with the hospital’s request for government money. The employee who understands the source’s movement can help explain how the billed quantity was chosen.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. Our work with you follows the sources into that payment claim, with the clinical explanation and the hospital’s billing decisions considered together.
C. R. Bard agreed to a $48.26 million civil settlement in 2013 over alleged benefits used to induce brachytherapy-seed purchases. The Justice Department’s announcement described alleged grants, rebates, conference fees, marketing assistance and free equipment to induce purchases. The whistleblower who brought the case was awarded about $10 million of the civil settlement.
Bard’s case concerned what customers were offered to choose the seeds. Source billing follows what happened to the prescribed product through treatment and into the hospital’s claim. The purchase and the billed count tell different parts of the story.
Medicare treats brachytherapy source storage as departmental overhead and prohibits a separate storage charge. A hospital’s storage expense therefore belongs in a different place from the separately payable radioactive source. For a billing employee, a storage line raises a question about the charge itself, alongside the question about source quantity.
The 2026 National Correct Coding Initiative manual treats dose calculations at multiple points as part of a single isodose-plan unit. If a billing instruction turns each calculation point into a separate plan, we want to understand who chose that unit count and what reached Medicare.
If your radiation-oncology, inventory or revenue-cycle work gives you the explanation behind the billed count, speak with our whistleblower experts about the sources and the charges. We build your strongest brachytherapy billing whistleblower case with you around the patient’s treatment, the sources acquired and the decisions that put those units on a Medicare claim. Our whistleblower experts stay with you throughout the case, bringing in healthcare fraud whistleblower lawyers who understand hospital reimbursement.